Skip to content

Felypressin

Drug profile

Also known as: octapressin, octopressin, phelypressin, PLV-2

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Felypressin is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including AVPR1A. Recorded indications include Local anesthesia.

  • Molecular targets: AVPR1A (1 listed in DrugCentral).
  • Indications: Local anesthesia.
  • Molecular formula: C46H65N13O11S2; molecular weight 1040.24 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Local anesthesia

Mechanism & targets

Molecular targets (1)

TargetGeneActionActivity
Vasopressin V1a receptorAVPR1Aagonist—

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Felypressin is on its molecule page.

Molecular formulaC46H65N13O11S2
Molecular weight1040.24 g/mol
CAS number—
InChIKeySFKQVVDKFKYTNA-DZCXQCEKSA-N
PubChem CID14257662
NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Felypressin used for?

DrugCentral lists the following indications for Felypressin: Local anesthesia.

How does Felypressin work?

Its molecular targets in DrugCentral include AVPR1A (agonist).

What is the chemical formula of Felypressin?

Felypressin has the molecular formula C46H65N13O11S2 and a molecular weight of 1040.24 g/mol.

Browse: all drugs starting with F · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets1
Indications1
FormulaC46H65N13O11S2
DrugCentral ID4910
Interactive profile